A study into the effectiveness of antibiotics in septic patients being treated with continuous renal replacement therapy has found the regimens to be ineffective in some cases.
A study into the effectiveness of antibiotics in septic patients being treated with continuous renal replacement therapy (CRRT) has found the regimens to be ineffective in some cases.
According to the study, published in Critical Care,1 sepsis is responsible for important alterations in the pharmacokinetics of antibiotics, and CRRT may contribute to further changes. The study aimed to determine whether the first dose of β-lactam pharmacokinetics piperacillin-tazobactam, ceftazidime, cefepime, and meropenem would result in adequate serum drug concentrations in patients with severe sepsis and septic shock.
Patients in four Belgian intensive care units with a diagnosis of severe sepsis or septic shock, in whom treatment with the study drugs was indicated, were included. Serum concentrations of the antibiotics were determined by high-pressure liquid chromatography (HPLC) from samples taken before and 1, 2, 5 and 6 or 12 hours after administration.
The study concluded that serum concentrations of the antibiotic after the first dose were acceptable only for meropenem. Standard dosage regimens for piperacillin-tazobactam, ceftazidime and cefepime may, therefore, be inadequate for severe sepsis and septic shock. It was recommended that for these latter drugs, higher doses and/or extended infusions should be used to optimize serum concentrations.
1. L. Seyler et al., Critical Care, 15, R137 (2011).
Inside the Laboratory: The Gionfriddo Group at the University of Buffalo
March 28th 2024In this edition of “Inside the Laboratory,” Emanuela Gionfriddo, PhD, an associate professor of chemistry at the University at Buffalo, discusses her group’s current research endeavors, including using solid-phase microextraction (SPME) coupled to liquid chromatography (LC) and gas chromatography (GC) to further understand the chemical relationship between environmental exposure and disease and elucidate micropollutants fate in the environment and biological systems.
Transferring Methods to Compact and Portable HPLC
February 14th 2024The current trend in laboratory equipment design is the miniaturization of laboratory instruments. Smaller-scale HPLC instruments offer benefits that cannot be matched by analytical-scale equipment, especially in the areas of portability, reduced fluid volumes, and reduced operating costs. Yet, the miniaturization of laboratory equipment has brought with it a unique set of challenges, including transferring methods to compact LC. Capillary LC expands the use of LC to applications not currently done using conventional LC in a wide array of application areas, including pharmaceutical, food and beverage, petrochemical, environmental, and oil and gas. Greg Ward, Axcend’s CEO wrote, “Customers want an HPLC system with a small footprint, low flow rates and green chemistry.” Join his podcast where he shares method transfer in these application areas.
Sustainable Green Solvents in Microextraction: A Review of Recent Advancements
March 27th 2024Conventional sample preparation can be time- and resource-consuming, and a green analytical methodology can be a game-changer for scientists, in addition to facilitating selective and sensitive separations.